Rubio-Rivas, ManuelMora-Lujan, Jose MariaFormiga, FrancescArevalo-Cañas, CoralLebron Ramos, Juan ManuelVillalba Garcia, Maria VictoriaFonseca Aizpuru, Eva MªDiez-Manglano, JesusArnalich Fernandez, FranciscoRomero Cabrera, Juan LuisGarcia Garcia, Gema MariaPesqueira Fontan, Paula MVargas Nuñez, Juan AntonioFreire Castro, Santiago JesusLoureiro Amigo, JosePascual Pérez, Maria de Los ReyesAlcala Pedrajas, Jose, NEncinas-Sanchez, DanielMella Perez, CarmenEna, JavierGracia Gutierrez, AnyuliEsteban Giner, Maria JoseVarona, Jose FMillan Nuñez-Cortes, JesusCasas-Rojo, Jose-Manuel2023-05-032023-05-032022-03-25Rubio-Rivas M, Mora-Luján JM, Formiga F, Arévalo-Cañas C, Lebrón Ramos JM, Villalba García MV, et al. WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales. J Gen Intern Med. 2022 Jun;37(8):1980-1987http://hdl.handle.net/10668/20842The WHO ordinal severity scale has been used to predict mortality and guide trials in COVID-19. However, it has its limitations. The present study aims to compare three classificatory and predictive models: the WHO ordinal severity scale, the model based on inflammation grades, and the hybrid model. Retrospective cohort study with patient data collected and followed up from March 1, 2020, to May 1, 2021, from the nationwide SEMI-COVID-19 Registry. The primary study outcome was in-hospital mortality. As this was a hospital-based study, the patients included corresponded to categories 3 to 7 of the WHO ordinal scale. Categories 6 and 7 were grouped in the same category. A total of 17,225 patients were included in the study. Patients classified as high risk in each of the WHO categories according to the degree of inflammation were as follows: 63.8% vs. 79.9% vs. 90.2% vs. 95.1% (p The present study proposes a new severity grading scale for COVID-19 hospitalized patients. In our opinion, it is the most informative, representative, and predictive scale in COVID-19 patients to date.enCOVID-19WHO ordinal scaleInflammationPrognosisCOVID-19HumansInflammationRetrospective StudiesSARS-CoV-2Treatment OutcomeWorld Health Organizationresearch article35396659open accessEstudios retrospectivosHumanosInflamacionOrganización Mundial de la SaludResultado del tratamientoSARS-CoV-210.1007/s11606-022-07511-71525-1497PMC8992782https://link.springer.com/content/pdf/10.1007/s11606-022-07511-7.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992782/pdf